|
|
Henry Schein Inc (NASDAQ: HSIC) |
|
|
|
| |
Henry Schein Inc 's Leverage Ratio
HSIC's quarterly Leverage Ratio and Total Liabilities, Equity growth
Due to net new borrowings of 5.34%, Leverage Ratio fell to 1.53, above the Henry Schein Inc 's average Leverage Ratio.
Within Medical Equipment & Supplies industry in the first quarter 2025, 33 other companies have achieved lower Leverage Ratio than Henry Schein Inc in the Q1 2025. While Leverage Ratio total ranking has improved so far in the first quarter 2025 to 656, from total ranking in the fourth quarter 2024 at 810 .
Explain Leverage Ratio?
How much Total Liabilitiess HSIC´s has?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| HSIC Leverage Ratio |
(Mar 29 2025)
Q1 |
(Dec 28 2024)
Q4 |
(Sep 28 2024)
Q3 |
(Jun 29 2024)
Q2 |
(Mar 30 2024)
Q1 |
| Y / Y Equity Change |
-6.68 % |
-6.02 % |
-3.29 % |
-0.91 % |
2.67 % |
| Y / Y Total Liabilities Change |
10.35 % |
-1.52 % |
18.87 % |
24.17 % |
35.29 % |
| Leverage Ratio MRQ |
1.53 |
1.43 |
1.45 |
1.36 |
1.3 |
| HSIC's Total
Ranking |
# 656 |
# 810 |
# 1288 |
# 1004 |
# 1314 |
| Seq. Equity Change |
-1.91 % |
-2.61 % |
-0.22 % |
-2.1 % |
-1.21 % |
| Seq. Total Liabilities Change |
5.34 % |
-4.21 % |
6.23 % |
2.95 % |
-5.99 % |
| Leverage Ratio first quarter 2025 Company Ranking |
| Within: |
No. |
| Medical Equipment & Supplies Industry |
# 34 |
| Healthcare Sector |
# 131 |
| Overall Market |
# 656 |
| Leverage Ratio Statistics |
| High |
Average |
Low |
| 1.57 |
1.08 |
0.74 |
| (Jun 30 2018) |
|
(Mar 31 2012) |
Cumulative Henry Schein Inc 's Leverage Ratio
HSIC's Leverage Ratio for the trailling 12 Months
HSIC Leverage Ratio |
(Mar 29 2025)
12 Months |
(Dec 28 2024)
12 Months |
(Sep 28 2024)
12 Months |
(Jun 29 2024)
12 Months |
(Mar 30 2024)
12 Months |
| Y / Y Equity TTM Growth |
-4.24 % |
-1.94 % |
0.75 % |
1.81 % |
1.79 % |
| Y / Y Total Liabilities TTM Growth |
12.1 % |
17.41 % |
29.21 % |
32.35 % |
32.41 % |
| Leverage Ratio TTM |
1.44 |
1.38 |
1.37 |
1.3 |
1.23 |
| Total Ranking TTM |
# 12
| # 1
| # 12
| # 5
| # 1527
|
| Seq. Equity TTM Growth |
-1.71 % |
-1.53 % |
-0.83 % |
-0.22 % |
0.65 % |
| Seq. Total Liabilities TTM Growth |
2.48 % |
-0.39 % |
4.33 % |
5.25 % |
7.34 % |
On the trailing twelve months basis Due to the net new borrowings of 5.34% during the trailing twelve months finishing in the Q1 2025, cumulativeLeverage Ratio improved to 1.44, above the Henry Schein Inc 's average Leverage Ratio. Leverage Ratio is the average cumulative value over the last four quarters.
Among companies in the Medical Equipment & Supplies industry HSIC recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has deteriorated during the twelve months ending in the Q1 2025, compared to the prior period, from 1 to 12.
Explain Leverage Ratio?
How much Total Liabilitiess HSIC´s has?
| TTM Leverage Ratio Company Ranking |
| Within: |
No. |
| Within the Medical Equipment & Supplies Industry |
# 0 |
| Healthcare Sector |
# 0 |
| Within the Market |
# 12 |
| trailing twelve months Leverage Ratio Statistics |
| High |
Average |
Low |
| 1.66 |
1.22 |
0.99 | | (Jun 30 2018) |
|
(Mar 27 2021) |
| Companies with similar Leverage Ratio in the quarter ending Mar 29 2025, within Medical Equipment & Supplies Industry | Leverage Ratio | Mar 29 2025 MRQ Total Liabilities | Mar 29 2025 MRQ Equity | | Zynex inc | 3.88 | $ 80.613 Millions | $ 20.774 Millions | | Neuropace Inc | 3.54 | $ 85.936 Millions | $ 24.269 Millions | | Tela Bio Inc | 3.26 | $ 59.128 Millions | $ 18.123 Millions | | Neuroone Medical Technologies Corp | 2.96 | $ 3.331 Millions | $ 1.126 Millions | | Bioventus Inc | 2.93 | $ 542.663 Millions | $ 185.479 Millions | | Cerus Corporation | 2.73 | $ 151.284 Millions | $ 55.492 Millions | | Orchestra Biomed Holdings Inc | 2.38 | $ 40.088 Millions | $ 16.857 Millions | | Adagio Medical Holdings inc | 2.33 | $ 28.939 Millions | $ 12.399 Millions | | Novocure Limited | 2.20 | $ 797.602 Millions | $ 361.958 Millions | | Transmedics Group Inc | 2.12 | $ 565.701 Millions | $ 266.308 Millions | | Vivani Medical Inc | 2.05 | $ 23.828 Millions | $ 11.624 Millions | | Baxter International Inc | 2.02 | $ 14,223.000 Millions | $ 7,054.000 Millions | | Dentsply Sirona Inc | 2.01 | $ 4,040.000 Millions | $ 2,010.000 Millions | | Neuronetics Inc | 2.01 | $ 79.339 Millions | $ 39.531 Millions | | Dexcom Inc | 1.94 | $ 4,395.000 Millions | $ 2,266.600 Millions | | Haemonetics Corporation | 1.83 | $ 1,499.343 Millions | $ 820.836 Millions | | Helius Medical Technologies inc | 1.72 | $ 2.204 Millions | $ 1.280 Millions | | Artivion Inc | 1.69 | $ 496.911 Millions | $ 294.252 Millions | | Insulet Corporation | 1.64 | $ 2,186.600 Millions | $ 1,330.700 Millions | | Henry Schein Inc | 1.53 | $ 6,058.000 Millions | $ 3,954.000 Millions | | Livanova Plc | 1.47 | $ 1,524.448 Millions | $ 1,034.298 Millions | | Integra Lifesciences Holdings Corp | 1.45 | $ 2,207.455 Millions | $ 1,524.139 Millions | | Masimo Corp | 1.42 | $ 1,346.700 Millions | $ 946.400 Millions | | The Pennant Group Inc | 1.36 | $ 440.026 Millions | $ 323.026 Millions | | U S Physical Therapy Inc | 1.28 | $ 640.602 Millions | $ 498.961 Millions | | Conmed Corporation | 1.28 | $ 1,250.095 Millions | $ 977.636 Millions | | Escalon Medical Corp | 1.27 | $ 2.921 Millions | $ 2.295 Millions | | Innovage Holding Corp | 1.19 | $ 291.043 Millions | $ 245.605 Millions | | Vaso Corporation | 1.13 | $ 30.245 Millions | $ 26.650 Millions | | Bausch and Lomb Corp | 1.10 | $ 7,067.000 Millions | $ 6,433.000 Millions |
|
